AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7971430 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 2462943 — intervention group
Group type: COMPARATOR
Intervention: Mantle field RT
Number of subjects: 1579
Study 2462943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mantle field plus paraaortic RT
Number of subjects: 1579
Study 2462943 — intervention group
Group type: EXPERIMENTAL
Intervention: MOPP chemotherapy and RT
Number of subjects: 1579
Study 2462943 — intervention group
Group type: COMPARATOR
Intervention: Total nodal irradiation
Number of subjects: 1579
Study 2462943 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MOPP-RT-3 MOPP
Number of subjects: 1579
Study 2462943 — intervention group
Group type: COMPARATOR
Intervention: 3 ABVD-RT-3 ABVD
Number of subjects: 1579
Study 2462943 — intervention group
Group type: EXPERIMENTAL
Intervention: RT alone
Number of subjects: 1579
Study 2462943 — intervention group
Group type: COMPARATOR
Intervention: CT
Number of subjects: 1579
Study 1276818 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose corticosteroids
Number of subjects: 26
Study 1276818 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-dose corticosteroids
Number of subjects: 26
Study 1276818 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose corticosteroids
Number of subjects: 26
Study 31511055 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep Water Running Interval Training (DWR-IT)
Number of subjects: 0
Study 31511055 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 28254959 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-supported cCBT (MoodGYM)
Number of subjects: 369
Study 28254959 — intervention group
Group type: COMPARATOR
Intervention: Minimally supported cCBT (MoodGYM)
Number of subjects: 369
Study 26095653 — intervention group
Group type: EXPERIMENTAL
Intervention: sIgE to Ara h 6
Number of subjects: 102
Study 26095653 — intervention group
Group type: EXPERIMENTAL
Intervention: sIgE to Ara h 2 and Ara h 6 together
Number of subjects: 102
Study 26095653 — intervention group
Group type: EXPERIMENTAL
Intervention: sIgE to Ara h 8
Number of subjects: 102
Study 26095653 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonroasted peanut
Number of subjects: 102
Study 26095653 — intervention group
Group type: EXPERIMENTAL
Intervention: Roasted peanut
Number of subjects: 102
Study 26095653 — intervention group
Group type: EXPERIMENTAL
Intervention: Component‐resolved diagnostics
Number of subjects: 102
Study 23529704 — intervention group
Group type: EXPERIMENTAL
Intervention: GDF‐15 concentrations
Number of subjects: 1817
Study 23529704 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in GDF‐15 concentrations
Number of subjects: 1817
Study 23529704 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline GDF‐15 concentrations
Number of subjects: 1817
Study 21948693 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise group (PEG) - 60 minutes of supervised exercise twice a week for 8 weeks
Number of subjects: 231
Study 21948693 — intervention group
Group type: COMPARATOR
Intervention: Control usual care group (UCG)
Number of subjects: 231
Study 21948693 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise group (PEG)
Number of subjects: 231
Study 18834820 — intervention group
Group type: EXPERIMENTAL
Intervention: Milrinone (50 microg/kg)
Number of subjects: 44
Study 18834820 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 21597981 — intervention group
Group type: EXPERIMENTAL
Intervention: Suppression condition
Number of subjects: 58
Study 21597981 — intervention group
Group type: COMPARATOR
Intervention: No Suppression condition
Number of subjects: 58
Study 21597981 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 58
Study 15756184 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of morphine, bupivacaine, and epinephrine
Number of subjects: 50
Study 15756184 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of bupivacaine and epinephrine
Number of subjects: 50
Study 15756184 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative analgesic injections
Number of subjects: 50
Study 15756184 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative analgesic injections
Number of subjects: 50
Study 15756184 — intervention group
Group type: COMPARATOR
Intervention: Preoperative treatment medication
Number of subjects: 50
Study 14677308 — intervention group
Group type: EXPERIMENTAL
Intervention: Quick Liberatory Rotation
Number of subjects: 300
Study 14677308 — intervention group
Group type: COMPARATOR
Intervention: Semont Technique
Number of subjects: 300
Study 14677308 — intervention group
Group type: COMPARATOR
Intervention: Parnes technique
Number of subjects: 300
Study 14677308 — intervention group
Group type: COMPARATOR
Intervention: Natural evolution (untreated patients)
Number of subjects: 300
Study 10214482 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg intramuscular ketorolac upon surgical closure and every 6 hours for 36 hours and narcotic analgesics as needed (PRN)
Number of subjects: 53
Study 10214482 — intervention group
Group type: COMPARATOR
Intervention: Only narcotic analgesics as needed
Number of subjects: 53
Study 7793999 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT (400 or 600 mg/body per day)
Number of subjects: 78
Study 7793999 — intervention group
Group type: COMPARATOR
Intervention: Non UFT group
Number of subjects: 78
Study 7793999 — intervention group
Group type: EXPERIMENTAL
Intervention: UFT group
Number of subjects: 78
Study 2191728 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 dB SPL tones
Number of subjects: 67
Study 2191728 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 dB tones
Number of subjects: 67
Study 436356 — intervention group
Group type: EXPERIMENTAL
Intervention: Xipamide
Number of subjects: 3
Study 436356 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide
Number of subjects: 3
Study 436356 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 3
Study 11605931 — intervention group
Group type: EXPERIMENTAL
Intervention: rapacuronium (1.5 mg/kg)
Number of subjects: 20
Study 11605931 — intervention group
Group type: COMPARATOR
Intervention: cis-atracurium (0.2 mg/kg)
Number of subjects: 20
Study 31021896 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-paced walking (6MW)
Number of subjects: 11
Study 31481980 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality Training Group (VRTG)
Number of subjects: 100
Study 31481980 — intervention group
Group type: COMPARATOR
Intervention: Traditional Cognitive Rehabilitation Group (TCRG)
Number of subjects: 100
Study 30201675 — intervention group
Group type: EXPERIMENTAL
Intervention: Tension and trauma release exercises (n = 9) for 6 weeks
Number of subjects: 18
Study 30201675 — intervention group
Group type: COMPARATOR
Intervention: Discussion group controls (n = 9) for 6 weeks
Number of subjects: 18
Study 27250713 — intervention group
Group type: EXPERIMENTAL
Intervention: Active low-level laser therapy (LLLT)
Number of subjects: 20
Study 27250713 — intervention group
Group type: COMPARATOR
Intervention: Placebo low-level laser therapy (LLLT)
Number of subjects: 20
Study 25419703 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarette use (EC use)
Number of subjects: 956
Study 23170867 — intervention group
Group type: EXPERIMENTAL
Intervention: Assimilated Turkish immigrant
Number of subjects: 340
Study 23170867 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Turkish immigrant
Number of subjects: 340
Study 23170867 — intervention group
Group type: COMPARATOR
Intervention: Neutral target
Number of subjects: 340
Study 19837071 — intervention group
Group type: EXPERIMENTAL
Intervention: Famotidine (40 mg, morning and evening)
Number of subjects: 160
Study 19837071 — intervention group
Group type: COMPARATOR
Intervention: Pantoprazole (20 mg in the morning and placebo in the evening)
Number of subjects: 160
Study 17531193 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency Management (CM)
Number of subjects: 142
Study 17531193 — intervention group
Group type: COMPARATOR
Intervention: Standard Treatment (ST)
Number of subjects: 142
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrient intake during the marathon (fluid, carbohydrate, energy, sodium)
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid intake
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate intake
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium intake
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss during the marathon
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Running time
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional recommendations compliance
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk of overhydration
Number of subjects: 42
Study 15714291 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of body composition and race experience with performance
Number of subjects: 42
Study 11928041 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium insufflation
Number of subjects: 33
Study 11928041 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Wall Lifting Technique (AWLT)
Number of subjects: 33
Study 11928041 — intervention group
Group type: COMPARATOR
Intervention: CO2 insufflation
Number of subjects: 33
Study 11928041 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including CO2, helium, AWLT)
Number of subjects: 33
Study 11928041 — intervention group
Group type: EXPERIMENTAL
Intervention: Helium insufflation and AWLT
Number of subjects: 33
Study 9527781 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir sulfate 400 mg
Number of subjects: 21
Study 9527781 — intervention group
Group type: EXPERIMENTAL
Intervention: Indinavir sulfate 800 mg
Number of subjects: 21
Study 8544974 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking with nicotine levels of < 0.1 mg
Number of subjects: 12
Study 8544974 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking with nicotine levels of 0.6 mg
Number of subjects: 12
Study 8544974 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking with nicotine levels of 1.0 mg
Number of subjects: 12
Study 8544974 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking with nicotine levels of 2.1 mg
Number of subjects: 12
Study 2404478 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatment leading to normalization of hemoglobin A1 value to 7.0% +/- 0.3%
Number of subjects: 42
Study 2404478 — intervention group
Group type: COMPARATOR
Intervention: Dietary treatment with persistent hyperglycemia (hemoglobin A1 value, 10.7% +/- 0.7%)
Number of subjects: 42
Study 698650 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasogastric suction
Number of subjects: 58
Study 698650 — intervention group
Group type: COMPARATOR
Intervention: No nasogastric suction
Number of subjects: 58
Study 30646965 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (accumulating dose of 45 to 63 mg/kg/day, dependent on age) as add-on to morphine
Number of subjects: 66
Study 30646965 — intervention group
Group type: COMPARATOR
Intervention: Placebo as add-on to morphine
Number of subjects: 66
Study 28266905 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial messages depicting health effects, appearance damage, or immediate risks
Number of subjects: 568
Study 28266905 — intervention group
Group type: COMPARATOR
Intervention: Text-only messages
Number of subjects: 568
Study 26202161 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumates@Work (R@W) program
Number of subjects: 64
Study 23866311 — intervention group
Group type: EXPERIMENTAL
Intervention: Be the Best You Can Be (BtBYCB) program
Number of subjects: 1333
Study 23866311 — intervention group
Group type: COMPARATOR
Intervention: Usual Personal, Social, and Health Education classes
Number of subjects: 1333
Study 20886228 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive stretching
Number of subjects: 16
Study 19501784 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 kcal snack packs
Number of subjects: 59
Study 19501784 — intervention group
Group type: COMPARATOR
Intervention: Standard size packages of snacks
Number of subjects: 59
Study 17035446 — intervention group
Group type: COMPARATOR
Intervention: Tiotropium (placebo-controlled trial)
Number of subjects: 1235
Study 12835212 — intervention group
Group type: EXPERIMENTAL
Intervention: Pacemaker programmed to 60 bpm
Number of subjects: 150
Study 12835212 — intervention group
Group type: COMPARATOR
Intervention: Pacemaker turned off
Number of subjects: 150
Study 12835212 — intervention group
Group type: COMPARATOR
Intervention: Prolonged follow-up with pacemakers turned off
Number of subjects: 150
Study 10373062 — intervention group
Group type: EXPERIMENTAL
Intervention: rhG‐CSF (5 microg/kg/day), n = 22
Number of subjects: 47
Study 10373062 — intervention group
Group type: COMPARATOR
Intervention: No rhG‐CSF, n = 25
Number of subjects: 47
Study 8901839 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro25 allele presence in patients with myocardial infarction
Number of subjects: 1192
Study 8901839 — intervention group
Group type: COMPARATOR
Intervention: Pro25 allele presence in control subjects
Number of subjects: 1192
Study 8901839 — intervention group
Group type: COMPARATOR
Intervention: Pro25 allele presence in relation to hypertension
Number of subjects: 1192
Study 1929514 — intervention group
Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol
Number of subjects: 21
Study 1929514 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo) nebulisation
Number of subjects: 21
Study 6750532 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir therapy (5 to 10 mg/kg/8 hours, 60 minutes intravenous infusions, three times a day for 6 or 11 days)
Number of subjects: 16
Study 6750532 — intervention group
Group type: EXPERIMENTAL
Intervention: Acyclovir therapy
Number of subjects: 16
Study 31256068 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking exercise (6 min standardized walking test)
Number of subjects: 35
Study 31256068 — intervention group
Group type: COMPARATOR
Intervention: Control condition (duration-matched quiet rest)
Number of subjects: 35
Study 29072242 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoVac system (n = 25)
Number of subjects: 50
Study 29072242 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional needle irrigation (n = 25)
Number of subjects: 50
Study 29072242 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozonated water (OW) + EDTA (n = 20)
Number of subjects: 50
Study 29072242 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl + EDTA (n = 20)
Number of subjects: 50
Study 29072242 — intervention group
Group type: COMPARATOR
Intervention: Saline (control, n = 10)
Number of subjects: 50
Study 26153199 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Observation of Procedural Skills (DOPS)
Number of subjects: 0
Study 26153199 — intervention group
Group type: COMPARATOR
Intervention: Routine evaluation method
Number of subjects: 0
Study 24709786 — intervention group
Group type: EXPERIMENTAL
Intervention: Postisometrical relaxation group (PIR group)
Number of subjects: 94
Study 24709786 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching combined with stabilizing exercise group (SE/SS group)
Number of subjects: 94
Study 24709786 — intervention group
Group type: EXPERIMENTAL
Intervention: Stabilizing exercise group (SS group)
Number of subjects: 94
Study 24709786 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 94
Study 21478189 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab 10 mg/kg
Number of subjects: 0
Study 21478189 — intervention group
Group type: COMPARATOR
Intervention: Infliximab 3 mg/kg
Number of subjects: 0
Study 21478189 — intervention group
Group type: COMPARATOR
Intervention: Infliximab 6 mg/kg
Number of subjects: 0
Study 19481433 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-limited NPPV with leakage during inspiration only (setting II)
Number of subjects: 14
Study 19481433 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-limited NPPV with leakage during inspiration and expiration (setting III)
Number of subjects: 14
Study 19481433 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-limited NPPV (setting II)
Number of subjects: 14
Study 19481433 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure-limited NPPV (setting III)
Number of subjects: 14
Study 19481433 — intervention group
Group type: COMPARATOR
Intervention: Volume-limited NPPV
Number of subjects: 14
Study 17032159 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavior therapy plus treatment as usual
Number of subjects: 0
Study 17032159 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual alone
Number of subjects: 0
Study 12751133 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiography
Number of subjects: 20
Study 12751133 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 20
Study 12751133 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood Pressure Measurement
Number of subjects: 20
Study 10946861 — intervention group
Group type: EXPERIMENTAL
Intervention: 17beta-estradiol (1 mg twice daily orally)
Number of subjects: 10
Study 10946861 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 (1 microg/kg x h)
Number of subjects: 10
Study 10946861 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined E2 and GHRP-2
Number of subjects: 10
Study 10946861 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRP-2 infusion
Number of subjects: 10
Study 10946861 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment with E2 and GHRP-2
Number of subjects: 10
Study 9506796 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycogen Depletion Exercise (GDE)
Number of subjects: 11
Study 9506796 — intervention group
Group type: COMPARATOR
Intervention: Control (no glycogen depletion)
Number of subjects: 11
Study 7844011 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead weights (0.8 to 2.0 g) glued to the upper lid with adhesive (Combihesive* or Tesafix)
Number of subjects: 48
Study 7844011 — intervention group
Group type: COMPARATOR
Intervention: Hour-glass dressing
Number of subjects: 48
Study 3041973 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination homeopathic preparation (Gripp-Heel)
Number of subjects: 170
Study 3041973 — intervention group
Group type: COMPARATOR
Intervention: Acetylsalicylic acid
Number of subjects: 170
Study 31493775 — intervention group
Group type: EXPERIMENTAL
Intervention: KC for 60 min daily
Number of subjects: 120
Study 31493775 — intervention group
Group type: EXPERIMENTAL
Intervention: KC for 120 min daily
Number of subjects: 120
Study 31493775 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (controls)
Number of subjects: 120
Study 30482739 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based telemanagement system (TECCU)
Number of subjects: 63
Study 30482739 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-assisted telephone care (G_NT)
Number of subjects: 63
Study 30482739 — intervention group
Group type: COMPARATOR
Intervention: Standard care (G_control)
Number of subjects: 63
Study 30482739 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (TECCU, G_NT, G_control)
Number of subjects: 63
Study 26563336 — intervention group
Group type: COMPARATOR
Intervention: ICD
Number of subjects: 143
Study 26563336 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 143
Study 26563336 — intervention group
Group type: COMPARATOR
Intervention: Phase SD
Number of subjects: 143
Study 26196695 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid (600-mg twice daily)
Number of subjects: 0
Study 26196695 — intervention group
Group type: EXPERIMENTAL
Intervention: No vasopressor receipt
Number of subjects: 0
Study 26196695 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral involvement
Number of subjects: 0
Study 26196695 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal renal function (eGFR 30-80 vs >80)
Number of subjects: 0
Study 23630950 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg QD for 12 weeks
Number of subjects: 171
Study 23630950 — intervention group
Group type: COMPARATOR
Intervention: Telmisartan 80 mg QD for 12 weeks
Number of subjects: 171
Study 20072091 — intervention group
Group type: EXPERIMENTAL
Intervention: Hextend (15 mL/kg administered during surgery)
Number of subjects: 54
Study 20072091 — intervention group
Group type: COMPARATOR
Intervention: Voluven (15 mL/kg administered during surgery)
Number of subjects: 54
Study 18230238 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive writing (writing about their traumatic experience)
Number of subjects: 25
Study 18230238 — intervention group
Group type: COMPARATOR
Intervention: Control group (writing about time management)
Number of subjects: 25
Study 16997114 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlexanox oral adhesive tablets applied 4 times a day for 5 days
Number of subjects: 212
Study 16997114 — intervention group
Group type: COMPARATOR
Intervention: Vehicle-control
Number of subjects: 212
Study 12235719 — intervention group
Group type: EXPERIMENTAL
Intervention: Echocardiographic screening
Number of subjects: 9697
Study 12235719 — intervention group
Group type: COMPARATOR
Intervention: Clinical assessment alone (Control)
Number of subjects: 9697
Study 10232632 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 50% of maximal oxygen consumption followed by a milk shake intake
Number of subjects: 8
Study 10232632 — intervention group
Group type: COMPARATOR
Intervention: Sedentary activities for 61 hours
Number of subjects: 8
Study 7790244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-neutron radiotherapy (20.4 Gy/12 fractions/4 weeks)
Number of subjects: 169
Study 7790244 — intervention group
Group type: COMPARATOR
Intervention: Conventional photon therapy (70 Gy/35 fractions/7 weeks)
Number of subjects: 169
Study 7790244 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-neutron radiotherapy
Number of subjects: 169
Study 7790244 — intervention group
Group type: COMPARATOR
Intervention: Conventional photon therapy
Number of subjects: 169
Study 2192184 — intervention group
Group type: EXPERIMENTAL
Intervention: Cepharanthin
Number of subjects: 94
Study 2192184 — intervention group
Group type: COMPARATOR
Intervention: S‐Adchnon (adrenochrome derivative)
Number of subjects: 94
Study 2192184 — intervention group
Group type: COMPARATOR
Intervention: Hythiol (L‐cysteine)
Number of subjects: 94